Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2021-06-10
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Birth Companion Intervention in Ethiopia, Kenya and Nigeria
NCT05565196
Blood-borne Infection Screening in an Afghan Antenatal Population
NCT01199601
Improving Uptake of Antenatal Care Services in Rural Côte d'Ivoire
NCT07341581
Impact of the Safe Childbirth Checklist in Luapula Province of Zambia Province of Zambia
NCT03263182
Postpartum Family Planning Service Through Enhanced Family Planning in Immunization Services
NCT01115361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although Cameroon introduced the HepB antigen as part of the Pentavalent vaccine into the immunization program in 2005, infants are currently unprotected until the first Penta shot at six weeks. Introduction of HepB-BD is a key priority for the Cameroon government through the National Cancer Strategy document as well as the Hepatitis Prevention and Treatment Guidelines. However, the timeliness of administration of Hepatitis B vaccine within 24 hours of birth is critical to ensure the highest efficacy and prevent transmission of the virus.
While coverage rates for BCG and OPV 0 are relatively high (91% and 78% respectively), these vaccines are often administered weeks or months after birth , not within the 24-hour timeframe recommended for Hepatitis B birth dose. Therefore, there are concerns from the Cameroon National Immunization Technical Advisory Group (NITAG) and other stakeholders on the feasibility of achieving high timely coverage of HepB-BD. The timeliness of administration of the birth dose vaccines within facilities relies on many system components including integrated processes between maternity and immunization units and healthcare worker awareness of birth dose administration guidelines.
The main aim of this pilot study is to assess the feasibility of immunizing newborns with BCG and OPV0 (and eventually HepB-BD) within 24 hours of birth by integrating routine immunization into maternity and immediate newborn care in 15 facilities in Cameroon.
Further, the specific objectives of this pilot study are to:
1. Integrate birth dose immunizations into maternity and immediate newborn care services
2. Measure the change in proportion of newborn receiving birth doses BCG and OPV0 within 24 hours compared to baseline data
3. Measure the change in average age of babies receiving birth doses of BCG and OPV0
4. Assess the operational feasibility and acceptability of interventions and describe any factors (barriers and enablers) that may influence further implementation of birth dose strategies
This feasibility assessment is to provide quantitative findings of an intervention integrating immunizations into maternity and newborn care across 15 health facilities in Cameroon. Overall, in 20 weeks an intervention phase will be followed by a final assessment. The approach will utilize quantitative data from healthcare worker surveys, the birth registry and immunization registry, and maternity unit reporting forms. The study findings will be used to inform strategy on HepB-BD introduction in Cameroon as well as interventions to strengthen service delivery structures for newborns.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Arm
These facilities will be those selected to have the intervention carried out.
Integration of vaccination services into delivery services
The purpose of the work is to integrate readily available birth dose vaccinations (Oral Polio and the Tuberculosis vaccine) currently given in a separate clinic into the maternity delivery services through improved training, checklist, and job aides.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integration of vaccination services into delivery services
The purpose of the work is to integrate readily available birth dose vaccinations (Oral Polio and the Tuberculosis vaccine) currently given in a separate clinic into the maternity delivery services through improved training, checklist, and job aides.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cameroon Expanded Program on Immunization
UNKNOWN
Bill and Melinda Gates Foundation
OTHER
Clinton Health Access Initiative Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ankouane Andoulo Firmin
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine and Bio-Medical Sciences, University of Yaoundé
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CMA Dibi
Dibi, Adamaoua Region, Cameroon
CMA Mbe
Mbé, Adamawe, Cameroon
HD Biyem-Assi
Biyem Assi, Center, Cameroon
HD Cite Verte
Cite Verte, Center, Cameroon
CMMR Etoudi
Djoungolo, Center, Cameroon
CMA Ahala
Efoulan, Center, Cameroon
CSIU Mbalmayo II
Mbalmayo, Center, Cameroon
CSC Nkoabang
Mfou, Center, Cameroon
Hospital Nicolas Barre
Nkolndongo, Center, Cameroon
HD Obala
Obala, Center, Cameroon
CSC Baham
Baham, West Region, Cameroon
HD Foumbot
Foumbot, West Region, Cameroon
HD Mifi
Mifi, West Region, Cameroon
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/09/1695/L/CNERSH/SP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.